The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prostate Cancer Screening-Global Market Insights and Sales Trends 2024
Synopsis
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
The global Prostate Cancer Screening market size is expected to reach US$ 22660 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate Cancer Screening in various end use industries. The expanding demands from the Hospitals, Clinics, Research Labs and Cancer Institutes, are propelling Prostate Cancer Screening market. Physical Exam, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laboratory Tests segment is estimated at % CAGR for the next seven-year period.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostate Cancer Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate Cancer Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate Cancer Screening covered in this report include Abbott Laboratories, Almac, Bayer, Beckman Coulter, BioméRieux, Genomic Health, Mayo Clinic, Mdxhealth and Roche Diagnostics, etc.
The global Prostate Cancer Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Almac
Bayer
Beckman Coulter
BioméRieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Global Prostate Cancer Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate Cancer Screening market, Segment by Type:
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Global Prostate Cancer Screening market, by Application
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate Cancer Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
The global Prostate Cancer Screening market size is expected to reach US$ 22660 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate Cancer Screening in various end use industries. The expanding demands from the Hospitals, Clinics, Research Labs and Cancer Institutes, are propelling Prostate Cancer Screening market. Physical Exam, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Laboratory Tests segment is estimated at % CAGR for the next seven-year period.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostate Cancer Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate Cancer Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate Cancer Screening covered in this report include Abbott Laboratories, Almac, Bayer, Beckman Coulter, BioméRieux, Genomic Health, Mayo Clinic, Mdxhealth and Roche Diagnostics, etc.
The global Prostate Cancer Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Almac
Bayer
Beckman Coulter
BioméRieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Global Prostate Cancer Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate Cancer Screening market, Segment by Type:
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Global Prostate Cancer Screening market, by Application
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate Cancer Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Prostate Cancer Screening
1.1 Prostate Cancer Screening Market Overview
1.1.1 Prostate Cancer Screening Product Scope
1.1.2 Prostate Cancer Screening Market Status and Outlook
1.2 Global Prostate Cancer Screening Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Prostate Cancer Screening Market Size by Region (2018-2029)
1.4 Global Prostate Cancer Screening Historic Market Size by Region (2018-2023)
1.5 Global Prostate Cancer Screening Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Prostate Cancer Screening Market Size (2018-2029)
1.6.1 North America Prostate Cancer Screening Market Size (2018-2029)
1.6.2 Europe Prostate Cancer Screening Market Size (2018-2029)
1.6.3 Asia-Pacific Prostate Cancer Screening Market Size (2018-2029)
1.6.4 Latin America Prostate Cancer Screening Market Size (2018-2029)
1.6.5 Middle East & Africa Prostate Cancer Screening Market Size (2018-2029)
2 Prostate Cancer Screening Market by Type
2.1 Introduction
2.1.1 Physical Exam
2.1.2 Laboratory Tests
2.1.3 Imaging Tests
2.1.4 Gleason Score
2.1.5 TNM Score
2.1.6 Genetic Tests
2.1.7 Digital Rectal Exam
2.1.8 Biopsy
2.2 Global Prostate Cancer Screening Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Prostate Cancer Screening Historic Market Size by Type (2018-2023)
2.2.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Prostate Cancer Screening Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Prostate Cancer Screening Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Prostate Cancer Screening Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Prostate Cancer Screening Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Prostate Cancer Screening Revenue Breakdown by Type (2018-2029)
3 Prostate Cancer Screening Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Research Labs
3.1.4 Cancer Institutes
3.1.5 Diagnostic Centers
3.1.6 Others
3.2 Global Prostate Cancer Screening Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Prostate Cancer Screening Historic Market Size by Application (2018-2023)
3.2.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Prostate Cancer Screening Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Prostate Cancer Screening Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Prostate Cancer Screening Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Prostate Cancer Screening Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Prostate Cancer Screening Revenue Breakdown by Application (2018-2029)
4 Prostate Cancer Screening Competition Analysis by Players
4.1 Global Prostate Cancer Screening Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Screening as of 2022)
4.3 Date of Key Players Enter into Prostate Cancer Screening Market
4.4 Global Top Players Prostate Cancer Screening Headquarters and Area Served
4.5 Key Players Prostate Cancer Screening Product Solution and Service
4.6 Competitive Status
4.6.1 Prostate Cancer Screening Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Prostate Cancer Screening Products, Services and Solutions
5.1.4 Abbott Laboratories Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Almac
5.2.1 Almac Profile
5.2.2 Almac Main Business
5.2.3 Almac Prostate Cancer Screening Products, Services and Solutions
5.2.4 Almac Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.2.5 Almac Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Prostate Cancer Screening Products, Services and Solutions
5.3.4 Bayer Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.3.5 Beckman Coulter Recent Developments
5.4 Beckman Coulter
5.4.1 Beckman Coulter Profile
5.4.2 Beckman Coulter Main Business
5.4.3 Beckman Coulter Prostate Cancer Screening Products, Services and Solutions
5.4.4 Beckman Coulter Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.4.5 Beckman Coulter Recent Developments
5.5 BioméRieux
5.5.1 BioméRieux Profile
5.5.2 BioméRieux Main Business
5.5.3 BioméRieux Prostate Cancer Screening Products, Services and Solutions
5.5.4 BioméRieux Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.5.5 BioméRieux Recent Developments
5.6 Genomic Health
5.6.1 Genomic Health Profile
5.6.2 Genomic Health Main Business
5.6.3 Genomic Health Prostate Cancer Screening Products, Services and Solutions
5.6.4 Genomic Health Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.6.5 Genomic Health Recent Developments
5.7 Mayo Clinic
5.7.1 Mayo Clinic Profile
5.7.2 Mayo Clinic Main Business
5.7.3 Mayo Clinic Prostate Cancer Screening Products, Services and Solutions
5.7.4 Mayo Clinic Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.7.5 Mayo Clinic Recent Developments
5.8 Mdxhealth
5.8.1 Mdxhealth Profile
5.8.2 Mdxhealth Main Business
5.8.3 Mdxhealth Prostate Cancer Screening Products, Services and Solutions
5.8.4 Mdxhealth Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.8.5 Mdxhealth Recent Developments
5.9 Roche Diagnostics
5.9.1 Roche Diagnostics Profile
5.9.2 Roche Diagnostics Main Business
5.9.3 Roche Diagnostics Prostate Cancer Screening Products, Services and Solutions
5.9.4 Roche Diagnostics Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.9.5 Roche Diagnostics Recent Developments
5.10 Rosetta Genomics
5.10.1 Rosetta Genomics Profile
5.10.2 Rosetta Genomics Main Business
5.10.3 Rosetta Genomics Prostate Cancer Screening Products, Services and Solutions
5.10.4 Rosetta Genomics Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.10.5 Rosetta Genomics Recent Developments
5.11 Thermo Fisher Scientific
5.11.1 Thermo Fisher Scientific Profile
5.11.2 Thermo Fisher Scientific Main Business
5.11.3 Thermo Fisher Scientific Prostate Cancer Screening Products, Services and Solutions
5.11.4 Thermo Fisher Scientific Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.11.5 Thermo Fisher Scientific Recent Developments
5.12 Hologic
5.12.1 Hologic Profile
5.12.2 Hologic Main Business
5.12.3 Hologic Prostate Cancer Screening Products, Services and Solutions
5.12.4 Hologic Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.12.5 Hologic Recent Developments
5.13 Myriad Genetics
5.13.1 Myriad Genetics Profile
5.13.2 Myriad Genetics Main Business
5.13.3 Myriad Genetics Prostate Cancer Screening Products, Services and Solutions
5.13.4 Myriad Genetics Prostate Cancer Screening Revenue (US$ Million) & (2018-2023)
5.13.5 Myriad Genetics Recent Developments
6 North America
6.1 North America Prostate Cancer Screening Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Prostate Cancer Screening Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Screening Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Prostate Cancer Screening Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Screening Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Prostate Cancer Screening Market Dynamics
11.1 Prostate Cancer Screening Industry Trends
11.2 Prostate Cancer Screening Market Drivers
11.3 Prostate Cancer Screening Market Challenges
11.4 Prostate Cancer Screening Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
